Cme Group annual net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cme Group Net Income Growth & History (CME)
Cme Group's net income was $4.07B for fiscal 2025.
View full Cme Group company overviewCme Group annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.07B | $546.4M | +15.50% |
| 2024 | 2024-12-31 | $3.53B | $299.8M | +9.29% |
| 2023 | 2023-12-31 | $3.23B | $535.0M | +19.88% |
| 2022 | 2022-12-31 | $2.69B | $54.0M | +2.05% |
| 2021 | 2021-12-31 | $2.64B | $531.0M | +25.21% |
| 2020 | 2020-12-31 | $2.11B | −$10.5M | −0.50% |
| 2019 | 2019-12-31 | $2.12B | $154.3M | +7.86% |
| 2018 | 2018-12-31 | $1.96B | −$2.10B | −51.71% |
| 2017 | 2017-12-31 | $4.06B | $2.53B | +164.87% |
| 2016 | 2016-12-31 | $1.53B | $287.1M | +23.02% |
| 2015 | 2015-12-31 | $1.25B | $119.9M | +10.64% |
| 2014 | 2014-12-31 | $1.13B | $150.3M | +15.39% |
| 2013 | 2013-12-31 | $976.8M | $80.5M | +8.98% |
| 2012 | 2012-12-31 | $896.3M | −$916.0M | −50.54% |
| 2011 | 2011-12-31 | $1.81B | $860.9M | +90.49% |
| 2010 | 2010-12-31 | $951.4M | $125.6M | +15.21% |
| 2009 | 2009-12-31 | $825.8M | $110.3M | +15.42% |
| 2008 | 2008-12-31 | $715.5M | $57.0M | +8.66% |
| 2007 | 2007-12-31 | $658.5M | — | — |
Cme Group quarterly net income
Q2.08
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.04B | $16.7M | +1.63% |
| Q1 2026 | 2026-03-31 | $1.15B | $198.1M | +20.72% |
| Q4 2025 | 2025-12-31 | $1.18B | $308.3M | +35.25% |
| Q3 2025 | 2025-09-30 | $908.0M | −$4.8M | −0.53% |
| Q2 2025 | 2025-06-30 | $1.03B | $141.9M | +16.07% |
| Q1 2025 | 2025-03-31 | $956.2M | $101.0M | +11.81% |
| Q4 2024 | 2024-12-31 | $874.6M | $60.2M | +7.39% |
| Q3 2024 | 2024-09-30 | $912.8M | $162.6M | +21.67% |
| Q2 2024 | 2024-06-30 | $883.2M | $105.6M | +13.58% |
| Q1 2024 | 2024-03-31 | $855.2M | −$28.6M | −3.24% |
| Q4 2023 | 2023-12-31 | $814.4M | $176.5M | +27.67% |
| Q3 2023 | 2023-09-30 | $750.2M | $70.6M | +10.39% |
| Q2 2023 | 2023-06-30 | $777.6M | $115.1M | +17.37% |
| Q1 2023 | 2023-03-31 | $883.8M | $172.8M | +24.30% |
| Q4 2022 | 2022-12-31 | $637.9M | $12.1M | +1.93% |
| Q3 2022 | 2022-09-30 | $679.6M | −$246.9M | −26.65% |
| Q2 2022 | 2022-06-30 | $662.5M | $152.2M | +29.83% |
| Q1 2022 | 2022-03-31 | $711.0M | $136.6M | +23.78% |
| Q4 2021 | 2021-12-31 | $625.8M | $201.8M | +47.59% |
| Q3 2021 | 2021-09-30 | $926.5M | $514.8M | +125.04% |
| Q2 2021 | 2021-06-30 | $510.3M | $7.0M | +1.39% |
| Q1 2021 | 2021-03-31 | $574.4M | −$191.8M | −25.03% |
| Q4 2020 | 2020-12-31 | $424.0M | −$45.5M | −9.69% |
| Q3 2020 | 2020-09-30 | $411.7M | −$224.6M | −35.30% |
| Q2 2020 | 2020-06-30 | $503.3M | −$10.5M | −2.04% |
| Q1 2020 | 2020-03-31 | $766.2M | $269.3M | +54.20% |
| Q4 2019 | 2019-12-31 | $469.5M | $84.0M | +21.79% |
| Q3 2019 | 2019-09-30 | $636.3M | $224.5M | +54.52% |
| Q2 2019 | 2019-06-30 | $513.8M | −$52.3M | −9.24% |
| Q1 2019 | 2019-03-31 | $496.9M | −$101.9M | −17.02% |
| Q4 2018 | 2018-12-31 | $385.5M | −$2.55B | −86.88% |
| Q3 2018 | 2018-09-30 | $411.8M | $103.2M | +33.44% |
| Q2 2018 | 2018-06-30 | $566.1M | $150.3M | +36.15% |
| Q1 2018 | 2018-03-31 | $598.8M | $199.0M | +49.77% |
| Q4 2017 | 2017-12-31 | $2.94B | $2.57B | +687.15% |
| Q3 2017 | 2017-09-30 | $308.6M | −$164.2M | −34.73% |
| Q2 2017 | 2017-06-30 | $415.8M | $95.7M | +29.90% |
| Q1 2017 | 2017-03-31 | $399.8M | $32.0M | +8.70% |
| Q4 2016 | 2016-12-31 | $373.4M | $81.7M | +28.01% |
| Q3 2016 | 2016-09-30 | $472.8M | $112.9M | +31.37% |
| Q2 2016 | 2016-06-30 | $320.1M | $55.1M | +20.79% |
| Q1 2016 | 2016-03-31 | $367.8M | $37.4M | +11.32% |
| Q4 2015 | 2015-12-31 | $291.7M | −$14.8M | −4.83% |
| Q3 2015 | 2015-09-30 | $359.9M | $69.9M | +24.10% |
| Q2 2015 | 2015-06-30 | $265.0M | $1.2M | +0.45% |
| Q1 2015 | 2015-03-31 | $330.4M | $63.6M | +23.84% |
| Q4 2014 | 2014-12-31 | $306.5M | $113.4M | +58.73% |
| Q3 2014 | 2014-09-30 | $290.0M | $53.3M | +22.52% |
| Q2 2014 | 2014-06-30 | $263.8M | −$47.4M | −15.23% |
| Q1 2014 | 2014-03-31 | $266.8M | $31.0M | +13.15% |
| Q4 2013 | 2013-12-31 | $193.1M | $26.3M | +15.77% |
| Q3 2013 | 2013-09-30 | $236.7M | $18.7M | +8.58% |
| Q2 2013 | 2013-06-30 | $311.2M | $66.3M | +27.07% |
| Q1 2013 | 2013-03-31 | $235.8M | −$30.8M | −11.55% |
| Q4 2012 | 2012-12-31 | $166.8M | −$579.1M | −77.64% |
| Q3 2012 | 2012-09-30 | $218.0M | −$98.1M | −31.03% |
| Q2 2012 | 2012-06-30 | $244.9M | −$48.8M | −16.62% |
| Q1 2012 | 2012-03-31 | $266.6M | −$190.0M | −41.61% |
| Q4 2011 | 2011-12-31 | $745.9M | $549.7M | +280.17% |
| Q3 2011 | 2011-09-30 | $316.1M | $71.8M | +29.39% |
| Q2 2011 | 2011-06-30 | $293.7M | $23.0M | +8.50% |
| Q1 2011 | 2011-03-31 | $456.6M | $216.4M | +90.09% |
| Q4 2010 | 2010-12-31 | $196.2M | −$6.4M | −3.16% |
| Q3 2010 | 2010-09-30 | $244.3M | $42.0M | +20.76% |
| Q2 2010 | 2010-06-30 | $270.7M | $48.9M | +22.05% |
| Q1 2010 | 2010-03-31 | $240.2M | $41.1M | +20.64% |
| Q4 2009 | 2009-12-31 | $202.6M | — | — |
| Q3 2009 | 2009-09-30 | $202.3M | $33.6M | +19.92% |
| Q2 2009 | 2009-06-30 | $221.8M | $20.6M | +10.24% |
| Q1 2009 | 2009-03-31 | $199.1M | — | — |
| Q3 2008 | 2008-09-30 | $168.7M | — | — |
| Q2 2008 | 2008-06-30 | $201.2M | — | — |
Cme Group net income trends
Over the last five fiscal years, Cme Group's net income increased from $2.11B to $4.07B, a change of $1.97B. The latest reported quarter, Q2 2026, shows $1.04B.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...